How should we use convalescent plasma therapies for the management of COVID-19? by Wood, EM, Estcourt, LJ, McQuilten, ZK

Clinical use of convalescent plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities by Al-Riyami, AZ, Schäfer, R, van den Berg, K, Bloch, EM, Estcourt, LJ, Goel, R, Hindawi, S, Josephson, CD, Land, K, McQuilten, ZK, Spitalnik, SL, Wood, EM, Devine, DV, So-Osman, C

Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial by Stanworth, SJ, Killick, S, McQuilten, ZK, Karakantza, M, Weinkove, R, Smethurst, H, Pankhurst, LA, Hodge, RL, Hopkins, V, Thomas, HL, Deary, AJ, Callum, J, Lin, Y, Wood, EM, Buckstein, R, Bowen, D, REDDS Investigators

Efficacy and safety analyses of recombinant factor VIIa in severe post-partum hemorrhage by Caram-Deelder, C, McKinnon Edwards, H, Zdanowicz, JA, van den Akker, T, Birkegård, C, Blatný, J, van der Bom, JG, Colucci, G, van Duuren, D, van Geloven, N, Henriquez, DDCA, Knight, M, Korsholm, L, Landorph, A, Lavigne Lissalde, G, McQuilten, ZK, Surbek, D, Wellard, C, Wood, EM, Mercier, FJ

Effect of convalescent plasma on organ support-free days in critically ill patients With COVID-19: a randomized clinical trial by Estcourt, LJ, Turgeon, AF, McQuilten, ZK, McVerry, BJ, Al-Beidh, F, Annane, D, Arabi, YM, Arnold, DM, Beane, A, Bégin, P, van Bentum-Puijk, W, Berry, LR, Bhimani, Z, Birchall, JE, Bonten, MJM, Bradbury, CA, Brunkhorst, FM, Buxton, M, Callum, JL, Chassé, M, Cheng, AC, Cove, ME, Daly, J, Derde, L, Detry, MA, De Jong, M, Evans, A, Fergusson, DA, Fish, M, Fitzgerald, M, Foley, C, Goossens, H, Gordon, AC, Gosbell, IB, Green, C, Haniffa, R, Harvala, H, Higgins, AM, Hills, TE, Hoad, VC, Horvat, C, Huang, DT, Hudson, CL, Ichihara, N, Laing, E, Lamikanra, AA, Lamontagne, F, Roberts, DJ